AHA files briefs in defense of Louisiana's 340B contract pharmacy law

Apr 21, 2025 - 03:09 PM
340B-update-900x400

The AHA April 18 filed friend-of-the-court briefs in three cases in support of Louisiana's 340B contract pharmacy law that prohibits drug companies from denying hospitals the same 340B discounts for drugs dispensed at community pharmacies that would be provided via in-house pharmacies. The briefs, filed in the U.S. Court of Appeals for the 5th Circuit, challenge claims by PhRMA, AbbVie and AstraZeneca that the federal law that created the 340B program preempts the state law.

The filings are the latest AHA has made in similar cases in multiple states. The AHA also filed friend-of-the-court briefs regarding the Louisiana cases in February 2024 and December 2023.

The Louisiana Hospital Association, Rural Hospital Coalition, 340B Health and the American Society of Health-System Pharmacists joined AHA in each of the latest filings.

Related News Articles

Headline
District court rules in favor of Tennessee’s 340B contract pharmacy law
The U.S. District Court for the Middle District of Tennessee June 30 denied a motion for a preliminary injunction by AbbVie in its lawsuit against the state’s…
Headline
AHA files amicus brief in second lawsuit challenging Tennessee’s 340B contract pharmacy law 
The AHA June 27 filed an amicus brief in the U.S. District Court for the Middle District of Tennessee that defends the state’s 340B contract pharmacy law…
Chairperson's File
Chair File: Leadership Dialogue — Legal Advocacy to Protect Hospitals With AHA General Counsel Chad Golder
Public
Advocacy is a core part of the work of the AHA, protecting and sustaining what hospitals and health systems need to truly care for our communities. We often…
Headline
Judge rules against J&J, for HHS and 340B hospitals in rebate model case
A U.S. District Court for the District of Columbia judge June 27 ruled against Johnson & Johnson and sided with the Department of Health and Human Services…
Headline
AHA report: Hospitals are complying with 340B rules, but drug companies are not 
The AHA June 16 released a report showing hospitals that participated in the 340B Drug Pricing Program are not only subject to disproportionately greater…
Chairperson's File
Chair File: The Importance of Legal Advocacy
Public
Advocacy is such an important part of what we do as hospitals and health systems — and what the AHA does on behalf of our field — to help ensure that we get…